Ruxolitinib cream for children with vitiligo
Treatments studied
Part of Skin clinical trials.
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 11 years old.
- Has nonsegmental vitiligo (patches on both sides of the body).
- Vitiligo covers at least a small area on the face and some other body parts, but less than 10% of total skin.
- Some of the vitiligo patches on the face have colored (not white) hairs inside them.
- Must stop using any other vitiligo treatments during the study.
- Child has not previously tried a JAK inhibitor treatment for vitiligo that failed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This trial tests an oral medication called zasocitinib to see if it can help repigment skin in adults with nonsegmental vitiligo. It may be an option for people whose vitiligo covers a moderate amount of their body and who have not had certain recent treatments.
This trial tests whether adding a daily nasal spray (Melanotan II) to light therapy helps restore color in stable vitiligo patches. It may be a good option for adults with mild to moderate nonsegmental vitiligo that hasn't changed in at least 6 months.
This study tests whether a cream called ruxolitinib can help restore skin color in children ages 2–11 with vitiligo, a condition causing white patches on the skin. The cream works by reducing inflammation that stops the body from making skin pigment.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
Hear when a new NonSegmental Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.